Pfizer’s COVID-19 vaccine becomes highest-selling pharmaceutical in history

Pfizer on Feb. 8 reported $36.8 billion in 2021 sales for its COVID-19 vaccine, making it the highest-selling pharmaceutical product in a single year.

Advertisement

Three things to know:

  1. In 2021, Pfizer hauled in $7.8 billion in U.S. COVID-19 vaccine sales and $29 billion in international sales.
  2. The second-highest sales of a pharmaceutical product in a single year also came in 2021, as AbbVie raked in $20.7 billion for its rheumatoid arthritis drug Humira.
  3. Pfizer controls about 70 percent of the COVID-19 vaccine market in the U.S. and Europe, according to Endpoints News.

At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.

Advertisement

Next Up in Pharmacy

Advertisement

Comments are closed.